Milestone Pharmaceuticals Inc.
NASDAQ:MIST
1.47 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | -0.868 | 0 | 0 | 1 | 3.5 | 1.5 | 0 | 0 | 15 | 0 | 15 | 0 | 57.444 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.026 | 0.028 | 0.532 | 0.024 | 0.024 | 0.018 | 0.406 | 9.826 | 0.024 | 0.023 | 0.292 | 0.024 | 9.427 | 0.023 | 28.722 | 8.228 | 8.622 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.026 | -0.028 | -1.4 | -0.024 | -0.024 | 0.982 | 3.094 | -8.326 | -0.024 | -0.023 | 14.708 | -0.024 | 5.573 | -0.023 | 28.722 | -8.228 | -8.622 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 1.613 | 0 | 0 | 0.982 | 0.884 | -5.551 | 0 | 0 | 0.981 | 0 | 0.372 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.88 | 3.707 | 5.434 | 6.721 | 8.622 | 10.257 | 10.578 | 9.826 | 10.657 | 8.768 | 10.916 | 9.733 | 9.427 | 8.595 | 5.766 | 8.228 | 8.622 | 11.872 | 14.149 | 9.545 | 10.527 | 7.765 | 7.297 | 3.911 | 2.551 | 3.091 |
| General & Administrative Expenses
| 5.046 | 3.953 | 3.371 | 4.227 | 4.445 | 3.889 | 4.123 | 4.034 | 3.918 | 3.643 | 3.787 | 2.961 | 3.018 | 2.633 | 1.674 | 2.952 | 2.956 | 2.703 | 2.279 | 2.104 | 1.641 | 0.979 | 1.218 | 0.646 | 0.75 | 0.439 |
| Selling & Marketing Expenses
| 1.801 | 2.884 | 4.977 | 4.412 | 3.369 | 2.356 | 2.558 | 2.67 | 2.231 | 1.636 | 2.215 | 1.579 | 1.843 | 1.366 | 1.322 | 0.905 | 1.527 | 2.183 | 2.464 | 2.076 | 2.166 | 2.186 | 1.592 | 1.228 | 0.375 | 0.725 |
| SG&A
| 6.821 | 6.809 | 7.908 | 8.639 | 7.814 | 6.245 | 6.681 | 6.704 | 6.149 | 5.279 | 6.002 | 4.54 | 4.861 | 3.999 | 2.996 | 3.857 | 4.483 | 4.886 | 4.743 | 4.18 | 3.807 | 3.165 | 2.81 | 1.874 | 1.125 | 1.164 |
| Other Expenses
| -0.065 | 0 | 0 | 0 | 0 | 0 | 48.924 | 2.67 | 2.231 | 0 | 45.674 | 0 | 1.843 | 0 | 0 | 0 | 0 | 0 | 8.892 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 9.701 | 10.516 | 13.342 | 15.36 | 16.436 | 16.502 | 17.259 | 16.53 | 16.806 | 14.047 | 16.918 | 14.273 | 14.288 | 12.594 | 8.762 | 12.085 | 13.105 | 16.758 | 18.892 | 13.725 | 14.334 | 10.93 | 10.107 | 5.785 | 3.676 | 4.255 |
| Operating Income
| -9.727 | -10.544 | -13.874 | -15.36 | -16.436 | -15.502 | -13.759 | -15.03 | -16.806 | -14.047 | -16.918 | -14.273 | 0.712 | -12.594 | -8.762 | -12.085 | -13.105 | -16.758 | -18.892 | -13.725 | -14.334 | -10.93 | -10.107 | -5.785 | -3.676 | -4.255 |
| Operating Income Ratio
| 0 | 0 | 15.984 | 0 | 0 | -15.502 | -3.931 | -10.02 | 0 | 0 | -1.128 | 0 | 0.047 | 0 | -0.153 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.299 | 0.122 | 0.189 | 0.279 | 0.393 | 0.552 | 0.582 | 0.474 | 0.158 | 0.04 | -0.034 | 0.048 | 0.058 | 0.08 | 0.096 | 0.089 | 0.126 | 0.415 | 0.603 | 0.821 | 0.672 | 0.5 | 0.446 | 0.085 | 0.089 | 0.09 |
| Income Before Tax
| -9.428 | -10.422 | -13.685 | -15.081 | -16.043 | -14.95 | -13.177 | -14.556 | -16.648 | -14.007 | -16.884 | -14.225 | 0.77 | -12.514 | -8.666 | -11.996 | -12.979 | -16.343 | -18.289 | -12.904 | -13.662 | -10.43 | -9.661 | -5.7 | -3.587 | -4.165 |
| Income Before Tax Ratio
| 0 | 0 | 15.766 | 0 | 0 | -14.95 | -3.765 | -9.704 | 0 | 0 | -1.126 | 0 | 0.051 | 0 | -0.151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.065 | -0.068 | -0.074 | 1.12 | 1.213 | -0.552 | -31.435 | -0.474 | -0.158 | -0.04 | 0.034 | -0.2 | -0.087 | -0.091 | 0.017 | -0.017 | 0 | 0 | -0.001 | -0.073 | -0.004 | 0.022 | 0.056 | 0 | 0.002 | 0.016 |
| Net Income
| -9.363 | -10.354 | -13.611 | -15.081 | -16.043 | -14.398 | 18.258 | -14.082 | -16.49 | -13.967 | -16.884 | -14.225 | 0.77 | -12.514 | -8.666 | -11.979 | -12.979 | -16.343 | -18.288 | -12.831 | -13.658 | -10.452 | -9.717 | -5.7 | -3.589 | -4.181 |
| Net Income Ratio
| 0 | 0 | 15.681 | 0 | 0 | -14.398 | 5.217 | -9.388 | 0 | 0 | -1.126 | 0 | 0.051 | 0 | -0.151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.14 | -0.21 | -0.41 | -0.35 | -0.37 | -0.34 | 0.43 | -0.33 | -0.39 | -0.33 | -0.4 | -0.34 | 0.02 | -0.3 | -0.29 | -0.4 | -0.53 | -0.67 | -0.75 | -0.52 | -1.04 | -0.45 | -0.41 | -0.24 | -0.15 | -0.18 |
| EPS Diluted
| -0.14 | -0.21 | -0.41 | -0.35 | -0.37 | -0.34 | 0.43 | -0.33 | -0.39 | -0.33 | -0.4 | -0.34 | 0.02 | -0.3 | -0.29 | -0.4 | -0.53 | -0.67 | -0.74 | -0.52 | -1.04 | -0.45 | -0.41 | -0.24 | -0.15 | -0.18 |
| EBITDA
| -9.701 | -10.516 | -13.342 | -14.216 | -15.199 | -15.502 | -13.759 | -15.003 | -16.782 | -14.024 | -16.895 | -14.249 | 0.735 | -12.571 | -8.737 | -12.062 | -13.08 | -16.734 | -18.868 | -13.716 | -14.332 | -10.927 | -10.105 | -5.782 | -3.673 | -4.253 |
| EBITDA Ratio
| 0 | 0 | 15.371 | 0 | 0 | -15.502 | -3.931 | -10.002 | 0 | 0 | -1.126 | 0 | 0.049 | 0 | -0.152 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |